Emergency Medicine Hub / Pediatrics & Obstetrics • 3 min read • 2 sections

Pediatric Lower Airway: Bronchiolitis & Acute Asthma

Comprehensive emergency evaluation and protocolized management of pediatric lower airway emergencies: viral bronchiolitis (Respiratory Syncytial Virus [RSV], human rhinovirus) in infants < 24 months, American Academy of Pediatrics (AAP) guidelines discouraging routine bronchodilators, steroids, or chest radiography; high-flow nasal cannula (HFNC) mechanisms; pediatric status asthmaticus management (continuous albuterol, ipratropium bromide, IV/oral dexamethasone, IV magnesium sulfate [50 mg/kg], IV terbutaline, and non-invasive ventilation).

Resuscitation Quick Actions • First 2 Minutes

High-Acuity

Bronchiolitis Guideline Rule

AAP: NO routine albuterol, NO steroids, NO chest X-rays, NO antibiotics; primary therapy is nasal suctioning + hydration

High-Flow Nasal Cannula

HFNC 1 to 2 L/kg/min (provides ~1 cmH2O PEEP per 1 L/kg flow); washes out dead space and reduces work of breathing

Pediatric Asthma First-Line

Continuous Albuterol (0.5 mg/kg/hr up to 15–20 mg/hr) + Ipratropium 0.5 mg nebulized q20m x 3 doses

Systemic Corticosteroids

Dexamethasone 0.6 mg/kg PO/IM (max 16 mg) once daily x 2 days OR Prednisolone 2 mg/kg PO (max 60 mg) daily x 5 days

IV Magnesium Sulfate

50 mg/kg IV over 20 minutes (max 2 grams); smooth muscle relaxation for refractory moderate-to-severe exacerbations

Subcutaneous Terbutaline/Epi

Terbutaline 0.01 mg/kg SC (max 0.25 mg) q20m x 3 OR Epinephrine 1:1,000 0.01 mg/kg SC/IM (max 0.3–0.5 mg) for severe bronchospasm

Pediatric Respiratory Assessment Measure (PRAM Score)

Validated clinical score (0-12) evaluating suprasternal retractions, scalene muscle contraction, air entry, wheezing, and SpO2 to guide acute asthma escalation.

Bottom-Line Clinical Pearl

In infants < 24 months with viral bronchiolitis (RSV), AAP clinical guidelines recommend AGAINST routine albuterol, epinephrine, corticosteroids, hypertonic saline, or antibiotics. The foundation of bronchiolitis care is supportive: nasal suctioning, gentle hydration, and heated humidified High-Flow Nasal Cannula (HFNC at 1–2 L/kg/min) for moderate-to-severe work of breathing. Conversely, pediatric asthma exacerbations require aggressive pharmacotherapy: Albuterol 2.5–5 mg continuous nebulization + Ipratropium 0.5 mg x 3 doses + Dexamethasone 0.6 mg/kg (or Prednisolone 2 mg/kg) + IV Magnesium Sulfate 50 mg/kg over 20 minutes for severe retractions or poor air movement.

1. Bronchiolitis: The Evidence-Based AAP Paradigm

Acute bronchiolitis is a seasonal viral lower respiratory tract infection occurring primarily in infants < 24 months of age, with peak incidence between 2 and 6 months. Respiratory Syncytial Virus (RSV) accounts for 50–80% of cases, followed by human rhinovirus and metapneumovirus. Pathophysiology involves viral necrosis of bronchiolar ciliated epithelial cells, lymphocytic infiltration, submucosal edema, and sloughing of epithelial debris into the small bronchiolar lumens, creating widespread plug-induced atelectasis and hyperinflation.

Intervention/Test	AAP Recommendation Status	Evidence & Clinical Rationale
Routine Bronchodilators (Albuterol/Levalbuterol)	NOT Recommended	Bronchiolar obstruction is driven by mechanical cellular debris and mucosal edema, not smooth muscle bronchospasm. Trials show no impact on hospitalization or illness duration.
Systemic Corticosteroids (Dexamethasone/Prednisone)	NOT Recommended	Multicenter RCTs demonstrate zero benefit in clinical scores, admission rates, or length of stay.
Routine Chest Radiography	NOT Recommended	Peribronchial cuffing and patchy viral atelectasis are routinely misinterpreted as bacterial pneumonia, driving inappropriate antibiotic use.
Routine Viral Panel Testing	NOT Recommended	Does not alter clinical management or disposition in straightforward presentations.
Nasal Suctioning & Hydration	Strongly Recommended	Infants are obligate nasal breathers; clearing the nares with saline drops and suction dramatically reduces work of breathing.
High-Flow Nasal Cannula (HFNC)	Recommended for Moderate/Severe	Heated, humidified gas at 1 to 2 L/kg/min washes out nasopharyngeal dead space, provides positive distending pressure (PEEP), and reduces intubation rates.

2. Pediatric Status Asthmaticus Resuscitation

In children $> 2\text{ years}$, reactive airway bronchospasm dominates. Severe status asthmaticus requires a prompt, multimodal escalation pathway to prevent respiratory muscle exhaustion and arrest:

Medication	Pediatric Dosing Regimen	Administration Route & Clinical Pearl
Albuterol (Continuous Nebulization)	0.5 mg/kg/hr continuous nebulization (max 15–20 mg/hr)	Inhaled; monitor for hypokalemia and lactic acidosis (type B beta-2 mediated).
Ipratropium Bromide	0.5 mg nebulized every 20 minutes for 3 doses	Inhaled; synergistic bronchodilation when combined with initial albuterol.
Dexamethasone	0.6 mg/kg PO/IM once daily for 2 days (max 16 mg)	Oral/IM; 2-day dexamethasone has equivalent efficacy to 5 days of prednisolone with far less vomiting.
Magnesium Sulfate IV	50 mg/kg IV infused over 20 minutes (max 2 grams)	IV piggyback in 100 mL NSS; inhibits calcium entry into bronchial smooth muscle.
Terbutaline IV/SC	0.01 mg/kg SC q20m x 3 doses OR IV load 10 mcg/kg over 10 min then 0.5–5 mcg/kg/min	Selective beta-2 agonist for severe refractory bronchospasm when aerosolized drug cannot penetrate plugged airways.

Board & Shelf Drill 5 Questions • Untimed Tutor Mode

Test Your Pediatric Lower Airway: Bronchiolitis & Acute Asthma Clinical Acumen

Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.

Related Emergency Protocols & Differentials

Related EM Protocol